{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/305085489"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "Physiologically and pharmaceutically acceptable carriers include diluents, fillers, salts buffers, stabilizers, solubilizers, and other materials which are well known in the art. [0070] A preferred embodiment of the invention relates to monoclonal antibodies whose heavy chains comprise in CDR3 the polypeptide PVANIDY, and/or whose light chains comprise in CDR3 the polypeptide QSYDSENPWV and conser" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "google.ca" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/463409996"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/305085489"] } } }
